An Unusual Dimeric Inhibitor of Acetylcholinesterase: Cooperative Binding of Crystal Violet
Acetylcholinesterase (AChE) is an essential enzyme that terminates cholinergic transmission by a rapid hydrolysis of the neurotransmitter acetylcholine. AChE is an important target for treatment of various cholinergic deficiencies, including Alzheimer’s disease and myasthenia gravis. In a previous h...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-08-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/22/9/1433 |
id |
doaj-1e9683bc80cc43f3a31ebf401b9f79d2 |
---|---|
record_format |
Article |
spelling |
doaj-1e9683bc80cc43f3a31ebf401b9f79d22020-11-25T01:02:12ZengMDPI AGMolecules1420-30492017-08-01229143310.3390/molecules22091433molecules22091433An Unusual Dimeric Inhibitor of Acetylcholinesterase: Cooperative Binding of Crystal VioletAnders Allgardsson0C. David Andersson1Christine Akfur2Franz Worek3Anna Linusson4Fredrik Ekström5Swedish Defence Research Agency, SE-90281 Umeå, SwedenDepartment of Chemistry, Umeå University, SE-90187 Umeå, SwedenSwedish Defence Research Agency, SE-90281 Umeå, SwedenDepartment of Toxicological Enzymology, Bundeswehr Institute of Pharmacology and Toxicology, 80937 Munich, GermanyDepartment of Chemistry, Umeå University, SE-90187 Umeå, SwedenSwedish Defence Research Agency, SE-90281 Umeå, SwedenAcetylcholinesterase (AChE) is an essential enzyme that terminates cholinergic transmission by a rapid hydrolysis of the neurotransmitter acetylcholine. AChE is an important target for treatment of various cholinergic deficiencies, including Alzheimer’s disease and myasthenia gravis. In a previous high throughput screening campaign, we identified the dye crystal violet (CV) as an inhibitor of AChE. Herein, we show that CV displays a significant cooperativity for binding to AChE, and the molecular basis for this observation has been investigated by X-ray crystallography. Two monomers of CV bind to residues at the entrance of the active site gorge of the enzyme. Notably, the two CV molecules have extensive intermolecular contacts with each other and with AChE. Computational analyses show that the observed CV dimer is not stable in solution, suggesting the sequential binding of two monomers. Guided by the structural analysis, we designed a set of single site substitutions, and investigated their effect on the binding of CV. Only moderate effects on the binding and the cooperativity were observed, suggesting a robustness in the interaction between CV and AChE. Taken together, we propose that the dimeric cooperative binding is due to a rare combination of chemical and structural properties of both CV and the AChE molecule itself.https://www.mdpi.com/1420-3049/22/9/1433cholinesteraseacetylcholinesterasecooperativitycrystal violetHill coefficientnew modalitynon-bonded bivalence |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Anders Allgardsson C. David Andersson Christine Akfur Franz Worek Anna Linusson Fredrik Ekström |
spellingShingle |
Anders Allgardsson C. David Andersson Christine Akfur Franz Worek Anna Linusson Fredrik Ekström An Unusual Dimeric Inhibitor of Acetylcholinesterase: Cooperative Binding of Crystal Violet Molecules cholinesterase acetylcholinesterase cooperativity crystal violet Hill coefficient new modality non-bonded bivalence |
author_facet |
Anders Allgardsson C. David Andersson Christine Akfur Franz Worek Anna Linusson Fredrik Ekström |
author_sort |
Anders Allgardsson |
title |
An Unusual Dimeric Inhibitor of Acetylcholinesterase: Cooperative Binding of Crystal Violet |
title_short |
An Unusual Dimeric Inhibitor of Acetylcholinesterase: Cooperative Binding of Crystal Violet |
title_full |
An Unusual Dimeric Inhibitor of Acetylcholinesterase: Cooperative Binding of Crystal Violet |
title_fullStr |
An Unusual Dimeric Inhibitor of Acetylcholinesterase: Cooperative Binding of Crystal Violet |
title_full_unstemmed |
An Unusual Dimeric Inhibitor of Acetylcholinesterase: Cooperative Binding of Crystal Violet |
title_sort |
unusual dimeric inhibitor of acetylcholinesterase: cooperative binding of crystal violet |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2017-08-01 |
description |
Acetylcholinesterase (AChE) is an essential enzyme that terminates cholinergic transmission by a rapid hydrolysis of the neurotransmitter acetylcholine. AChE is an important target for treatment of various cholinergic deficiencies, including Alzheimer’s disease and myasthenia gravis. In a previous high throughput screening campaign, we identified the dye crystal violet (CV) as an inhibitor of AChE. Herein, we show that CV displays a significant cooperativity for binding to AChE, and the molecular basis for this observation has been investigated by X-ray crystallography. Two monomers of CV bind to residues at the entrance of the active site gorge of the enzyme. Notably, the two CV molecules have extensive intermolecular contacts with each other and with AChE. Computational analyses show that the observed CV dimer is not stable in solution, suggesting the sequential binding of two monomers. Guided by the structural analysis, we designed a set of single site substitutions, and investigated their effect on the binding of CV. Only moderate effects on the binding and the cooperativity were observed, suggesting a robustness in the interaction between CV and AChE. Taken together, we propose that the dimeric cooperative binding is due to a rare combination of chemical and structural properties of both CV and the AChE molecule itself. |
topic |
cholinesterase acetylcholinesterase cooperativity crystal violet Hill coefficient new modality non-bonded bivalence |
url |
https://www.mdpi.com/1420-3049/22/9/1433 |
work_keys_str_mv |
AT andersallgardsson anunusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet AT cdavidandersson anunusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet AT christineakfur anunusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet AT franzworek anunusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet AT annalinusson anunusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet AT fredrikekstrom anunusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet AT andersallgardsson unusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet AT cdavidandersson unusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet AT christineakfur unusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet AT franzworek unusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet AT annalinusson unusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet AT fredrikekstrom unusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet |
_version_ |
1725206090997563392 |